Bioniz Therapeutics Inc
Edit

Bioniz Therapeutics Inc

http://bioniz.com/
Tags:DevelopmentMedtechProduct
Bioniz Therapeutics is a private biopharmaceutical company leading the discovery and development of first-in-class anti-cytokine therapies to treat cancer and autoimmune diseases driven by unregulated T-cell biology. Bioniz leverages its world class expertise in cytokine biology to develop a pipeline of novel peptide therapeutics to selectively inhibit functionally redundant cytokines while leaving the rest of the cytokine network intact. The company’s lead product candidate, BNZ-1, has successfully completed a Phase 1/2 clinical trial in Refractory Cutaneous T-cell lymphoma (rCTCL). Bioniz is also evaluating BNZ-1 for the treatment of autoimmune diseases, including alopecia areata and vitiligo. BNZ-2 and BNZ-3 are being developed as potential treatments for celiac disease and inflammatory bowel disease.
Location: United States, California, Irvine
Member count: 11-50
Total raised: $13M
Founded date: 2010

Investors 3

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
01.08.2016-$13M-socaltech....

Mentions in press and media 3

DateTitleDescriptionCategoryAuthorSource
19.08.2016OCTANe’s a...“When a company comes through ...--medcitynew...
01.08.2016 Bioniz...Irvine-based Bioniz Therapeuti...--socaltech....
-OCTANe’s a...Startups have a burning need t...--medcitynew...